Intentar ORO - Gratis
THE Beautiful AND THE Damned
Newsweek US
|May 09, 2025
How GLP-1 drugs like MOUNJARO and OZEMPIC are redefining the debate about size, weight loss and PRIVILEGE

SAMHITA MUKHOPADHYAY WASN'T expecting shame to come from a photo. The longtime feminist writer and former Teen Vogue editor had just moderated a panel at a media conference. She was dressed in a skirt and printed top she felt good in—until she saw a candid image someone had posted online. “It was devastating,” she told Newsweek. Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, sleeping more soundly and even considering a wardrobe overhaul. But the cost of the drug forced her to stop. “I knew better,” she said. “As a feminist writer and committed proponent of body positivity, I'd spent years trying to love my body at any size. And yet, here I was, agonizing over a picture of myself.
That contradiction, she said, was the real heartbreak—not just for her, but for the women who long-embraced the body positivity messaging themselves. “Taking something for weight loss made me feel like I was being vain, that I didn’t have the willpower to lose weight, eat better or exercise,” she said. “It felt like a violation of an unspoken norm.”
Hollywood's Open Secret
IN RECENT YEARS, MOUNJARO AND SIMILAR GLP-1 DRUGS like Wegovy, Ozempic and Zepbound have redefined how America thinks—and talks—about weight. What began as a diabetes treatment has become a billion-dollar industry fueled by off-label use, celebrity whispers and red-carpet transformations.
As the 2025 Hollywood awards season kicked off with the Golden Globes in January, so too did another round of jokes, speculation and sponsorships linking the industry to the use of GLP-1 medications for weight loss by A-list celebrities. Comedian Nikki Glaser, host of the Globes, dove right in at the start of her opening monologue: “Good evening, and welcome to the 82nd Golden Globes—Ozempic’s biggest night,” she began.
Esta historia es de la edición May 09, 2025 de Newsweek US.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Newsweek US

Newsweek US
Jesse Williams
FOR HOTEL COSTIERA, JESSE WILLIAMS WAS DRAWN TO MAKING “SOME- thing that’s global.” The new Prime Video series stars Williams as Daniel De Luca, a former Marine who returns home to Italy to work at a hotel, only to find himself tasked with finding the missing daughter of the hotel’s owner. While he has “no complaints” filming in Positano paradise, “I tried to stay rela- tively disciplined, but I ate a lot of pasta and bread.” Of the character, he related to his duality. “I don’t really say I’m half anything,” he notes. “That has to have found itself stewing in something Daniel De Luca is dealing with.” The series represents a new phase for Williams, taking creative control as a producer. “It certainly feels good...to bet on you in the same way you're trying to bet on your- self.” After leaving his role on Grey’s Anatomy, his first move was a deliberate challenge, Broadway, and now this, raising the stakes by creating an original show. “Like, it’s really trying to forge something new in a space.” But ultimately, it’s all about the process. “I love the collaboration that exists in our business.”
1 min
October 10, 2025

Newsweek US
Elvira
ELVIRA FIRMLY BELIEVES HALLOWEEN requires spooky snacks, and she's here to provide some inspiration with Elvira's Cookbook from Hell: Sexy, Spooky Soirées and Celebrations for Every Occasion.
2 mins
October 10, 2025

Newsweek US
Freeing the Bird
Elon Musk said he purchased Twitter to champion free speech, but this exclusive excerpt says it was more about advancing a personal, right-leaning agenda
12 mins
October 10, 2025

Newsweek US
'This Has Changed the Region Forever'
Qatari spokesperson Majed al-Ansari tells Newsweek of Gulf leaders' plans to warn President Donald Trump of a \"new threat perception\" following Israel's strikes in Doha
11 mins
October 10, 2025

Newsweek US
STREETS AHEAD
CHINA IS IN THE DRIVER'S SEAT WHEN IT NATIONAL SECURITY IMPLICATIONS FOR THE U.S. COMES TO EV TECHNOLOGY-WHICH POSES HUGE
12 mins
October 10, 2025

Newsweek US
Beyond Skin Deep
After walking away from her namesake brand, Bobbi Brown is proving reinvention can be as powerful as invention
6 mins
October 10, 2025

Newsweek US
Food for Thought
Americans are increasing their protein intake, but at what cost to the sustainable food movement?
4 mins
October 10, 2025
Newsweek US
Britain's MAGA Moment
Former Prime Minister Liz Truss' hopes for a right-wing overhaul
3 mins
October 10, 2025

Newsweek US
Poles Apart
Egypt and Saudi Arabia's clash of governing philosophies is accelerating schisms across the Middle East and North Africa
3 mins
October 10, 2025

Newsweek US
AMERICA'S MOST Admired WORKPLACES 2026
WHEN PEOPLE CONSIDER THEIR DREAM JOB, they often put companies they admire at the top of the list.
4 mins
October 03, 2025
Listen
Translate
Change font size